BARACLUDE Safety Questions, BARACLUDE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about BARACLUDE. Our extensive database of BARACLUDE adverse events and BARACLUDE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about BARACLUDE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



BARACLUDE Safety Reports

Total BARACLUDE reports: 169.
BARACLUDE FDA safety alerts: 2007 .
Reported deaths: 36    Reported hospitalizations: 70.
Take BARACLUDE Side Effects Survey or Share Your BARACLUDE Story. BARACLUDE Usage.

Showing 1-75 of 169 Next >

Consumer or non-health professional from AUSTRALIA reported BARACLUDE problem on May 24, 2007. Male patient, 40 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Physician from TURKEY on May 25, 2007. Female patient, 31 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: myalgia, pain in extremity. BARACLUDE dosage: unknown. Patient recovered.

Consumer or non-health professional from TURKEY reported BARACLUDE problem on May 25, 2007. Male patient, 34 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: myalgia, pain in extremity. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Physician from AUSTRALIA on May 25, 2007. Male patient, 65 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: renal failure. BARACLUDE dosage: unknown. Patient recovered.

Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on May 21, 2007. Male patient, 54 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatocellular damage, renal failure. BARACLUDE dosage: unknown. Patient was hospitalized. Patient died on 05/01/2007.

BARACLUDE problem was reported by a Health Professional from AUSTRALIA on May 25, 2007. Male patient, 35 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. BARACLUDE dosage: unknown. Patient recovered.

Physician from SWEDEN reported BARACLUDE problem on May 29, 2007. Male patient, 76 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, sepsis. BARACLUDE dosage: unknown. Patient died.

BARACLUDE problem was reported by a Physician from JAPAN on May 28, 2007. Male patient, 37 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, myalgia, white blood cell count increased. BARACLUDE dosage: unknown. During the same period patient was treated with NEO MINOPHAGEN C. Patient recovered.

Physician from JAPAN reported BARACLUDE problem on May 29, 2007. Male patient, 49 years of age, was diagnosed with hepatic cirrhosis and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, white blood cell count decreased. BARACLUDE dosage: unknown. During the same period patient was treated with LASIX, ALDACTONE, LIVACT. Patient recovered.

BARACLUDE problem was reported by a Health Professional from JAPAN on May 29, 2007. Male patient, 50 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction. BARACLUDE dosage: unknown. Patient recovered.

Consumer or non-health professional from INDIA reported BARACLUDE problem on June 06, 2007. Male patient, 40 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. BARACLUDE dosage: THE PATIENT STARTED ON .05 MG ON 31-JUL-2006, AFTER 3 MONTHS THE WAS INCREASED TO 1 MG.. Patient was hospitalized. Patient died.

BARACLUDE problem was reported by a Physician from TURKEY on June 06, 2007. Female patient, 31 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: myalgia, pain in extremity. BARACLUDE dosage: unknown. Patient recovered.

Consumer or non-health professional from TURKEY reported BARACLUDE problem on June 06, 2007. Male patient, 34 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: myalgia, pain in extremity. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Physician from JAPAN on June 05, 2007. Male patient, 49 years of age, was diagnosed with hepatic cirrhosis and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic function abnormal, white blood cell count decreased. BARACLUDE dosage: unknown. During the same period patient was treated with LASIX, ALDACTONE, LIVACT. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported BARACLUDE problem on June 07, 2007. Male patient, 59 years of age, was diagnosed with hepatitis b, blood pressure increased, ankylosing spondylitis and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: blood hiv rna decreased. BARACLUDE dosage: unknown. During the same period patient was treated with AMLODIPINE, SULFASALAZINE. Patient recovered.

BARACLUDE problem was reported by a Physician from FRANCE on June 08, 2007. Male patient, 32 years of age, was diagnosed with hepatitis b, renal transplant and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: gingival bleeding, haemoptysis, pancreatitis. BARACLUDE dosage: unknown. During the same period patient was treated with CELLCEPT, PROGRAF. Patient recovered.

Physician from TURKEY reported BARACLUDE problem on June 18, 2007. Female patient, 31 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: myalgia, pain in extremity. BARACLUDE dosage: unknown. During the same period patient was treated with CIPRAM. Patient recovered.

BARACLUDE problem was reported by a Physician from UNITED STATES on Mar 22, 2007. Male patient, 49 years of age, weighting 145.5 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, depression, fatigue. BARACLUDE dosage: unknown. During the same period patient was treated with METHADONE, FOSAMAX, LEXAPRO. Patient recovered.

Physician from UNITED STATES reported BARACLUDE problem on Apr 06, 2007. Male patient, 23 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: acarodermatitis, dermatitis contact. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Female patient, 32 years of age, weighting 255.7 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: pregnancy. BARACLUDE dosage: unknown. During the same period patient was treated with PRENATAL VITAMINS. Patient recovered.

Physician from UNITED STATES reported BARACLUDE problem on Apr 10, 2007. Female patient, 51 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: dizziness, palpitations, rash. BARACLUDE dosage: unknown. During the same period patient was treated with TOPROL. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Male patient, child 9 years of age, was diagnosed with hepatitis b, cough and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: viral load increased. BARACLUDE dosage: unknown. During the same period patient was treated with ADDERALL, FOCALIN, CLONIDINE, ABILIFY, DETROL LA, PSEUDOEPHEDRINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BARACLUDE problem on May 08, 2007. Male patient, 34 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: therapeutic response decreased. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Physician from UNITED STATES on May 11, 2007. Male patient, 48 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: pain. BARACLUDE dosage: unknown. Patient recovered.

Consumer or non-health professional from INDIA reported BARACLUDE problem on June 19, 2007. Male patient, 40 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. BARACLUDE dosage: THE PATIENT STARTED ON .05 MG ON 31-JUL-2006, AFTER 3 MONTHS THE WAS INCREASED TO 1 MG.. Patient was hospitalized. Patient died.

BARACLUDE problem was reported by a Physician from GERMANY on June 25, 2007. Male patient, 67 years of age, weighting 178.6 lb, was diagnosed with hepatitis b, coronary artery bypass, coronary artery disease, hypertension and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hypertension. BARACLUDE dosage: unknown. During the same period patient was treated with PLAVIX, ACERCOMP, CARVEDILOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on June 25, 2007. Male patient, 52 years of age, was treated with BARACLUDE. BARACLUDE dosage: unknown. Patient died on 06/04/2007.

BARACLUDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 07, 2006. Male patient, 50 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: renal failure. BARACLUDE dosage: unknown. During the same period patient was treated with RAPAMUNE. Patient was hospitalized. Patient recovered.

Physician from CHINA reported BARACLUDE problem on July 17, 2006. Male patient, 41 years of age, weighting 132.3 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, retinal haemorrhage. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Health Professional from UNITED STATES on Sept 01, 2006. Male patient, weighting 266.0 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: chromaturia, rhabdomyolysis. BARACLUDE dosage: 0.5 MG QD PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported BARACLUDE problem on June 13, 2006. Female patient, weighting 143.3 lb, was diagnosed with hepatitis b, seasonal allergy and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: pregnancy. BARACLUDE dosage: unknown. During the same period patient was treated with ZYRTEC. Patient recovered.

BARACLUDE problem was reported by a Pharmacist from UNITED STATES on July 18, 2006. Male patient, 52 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: fatigue, weight decreased. BARACLUDE dosage: unknown. During the same period patient was treated with ALPRAZOLAM, NORCO, AMBIEN. Patient recovered.

Consumer or non-health professional from CHINA reported BARACLUDE problem on Mar 22, 2006. Male patient, 44 years of age, was diagnosed with chronic hepatitis and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anorexia, blood bilirubin increased, insomnia, ocular icterus. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2006. Female patient, 60 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CHINA reported BARACLUDE problem on Oct 23, 2006. Male patient, 63 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant, metastases to lymph nodes. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from CHINA on Oct 23, 2006. Male patient, 63 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant, metastases to lymph nodes. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CHINA reported BARACLUDE problem on Oct 23, 2006. Male patient, 63 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, hepatic neoplasm malignant, metastases to lymph nodes, splenomegaly. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from SINGAPORE on Nov 09, 2006. Male patient, 44 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: peritonitis bacterial, septic shock. BARACLUDE dosage: unknown. During the same period patient was treated with LAMIVUDINE, ANTIBIOTICS. Patient died on 08/30/2006.

Consumer or non-health professional from INDIA reported BARACLUDE problem on Oct 27, 2006. Male patient, 55 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. BARACLUDE dosage: unknown. Patient died.

BARACLUDE problem was reported by a Physician from UNITED STATES on Oct 18, 2006. Female patient, 60 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis. BARACLUDE dosage: unknown. During the same period patient was treated with PROCARDIA, DYAZIDE, ESTAZOLAM, PROZAC, VITAMIN E. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on Oct 27, 2006. Female patient, 45 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatitis b virus. BARACLUDE dosage: unknown. Patient died.

BARACLUDE problem was reported by a Health Professional from INDIA on Oct 26, 2006. Male patient, 59 years of age, was diagnosed with hepatitis b, candidiasis and was treated with BARACLUDE. BARACLUDE dosage: unknown. During the same period patient was treated with BACLOFEN, FORCAN. Patient died.

Physician from CHINA reported BARACLUDE problem on Nov 20, 2006. Male patient, 42 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant, portal vein thrombosis, splenomegaly. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Physician from SINGAPORE on Nov 23, 2006. Male patient, 21 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic encephalopathy. BARACLUDE dosage: unknown. Patient died on 11/21/2006.

Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on Nov 23, 2006. Female patient, 66 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. BARACLUDE dosage: unknown. Patient died.

BARACLUDE problem was reported by a Consumer or non-health professional from SINGAPORE on Nov 28, 2006. Male patient, 44 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. BARACLUDE dosage: unknown. Patient died on 11/14/2006.

Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on Dec 06, 2006. Male patient, 61 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hypotension. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from CHINA on Oct 23, 2006. Male patient, 63 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, hepatic neoplasm malignant, metastases to lymph nodes, splenomegaly. BARACLUDE dosage: unknown. Patient was hospitalized. Patient died on 12/07/2006.

Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on Dec 12, 2006. Male patient, 61 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatorenal syndrome. BARACLUDE dosage: unknown. Patient died on 12/12/2006.

BARACLUDE problem was reported by a Consumer or non-health professional from INDIA on Nov 28, 2006. Male patient, 44 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis. BARACLUDE dosage: unknown. Patient died on 11/14/2006.

Health Professional from UNITED STATES reported BARACLUDE problem on Oct 06, 2006. Male patient, 36 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: viral load increased. BARACLUDE dosage: unknown. During the same period patient was treated with PAXIL. Patient recovered.

BARACLUDE problem was reported by a Physician from UNITED STATES on Oct 26, 2006. Male patient, 57 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. BARACLUDE dosage: unknown. During the same period patient was treated with CLARITIN, IBUPROFEN, ALCOHOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CHINA reported BARACLUDE problem on Dec 18, 2006. Male patient, 47 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatitis fulminant. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Physician from CHINA on Dec 18, 2006. Male patient, 52 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatitis fulminant. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from SWEDEN reported BARACLUDE problem on June 26, 2007. Male patient, 75 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, sepsis. BARACLUDE dosage: unknown. During the same period patient was treated with SIMVASTATIN, MINIDIAB, TENORMIN, ZOLPIDEM TARTRATE, ATACAND HCT. Patient was hospitalized. Patient died.

BARACLUDE problem was reported by a Health Professional from JAPAN on July 02, 2007. Male patient, 50 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction. BARACLUDE dosage: unknown. Patient recovered.

Physician from AUSTRALIA reported BARACLUDE problem on June 26, 2007. Male patient, 67 years of age, weighting 202.8 lb, was diagnosed with hepatitis b virus and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: renal failure. BARACLUDE dosage: unknown. During the same period patient was treated with HUMALOG, ATENOLOL, LERCANIDIPINE, CANDESARTAN CILEXETIL, PERINDOPRIL, FRUSEMIDE, ADEFOVIR DIPIVOXIL, LAMIVUDINE. Patient was hospitalized and became disabled. Patient recovered.

BARACLUDE problem was reported by a Physician from JAPAN on June 27, 2007. Male patient, 60 years of age, was diagnosed with hepatitis b, gastric ulcer, ascites and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: renal failure acute. BARACLUDE dosage: unknown. During the same period patient was treated with PARIET, LASIX, SPIRONOLACTONE, SELBEX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from PHILIPPINES reported BARACLUDE problem on June 27, 2007. Male patient, 49 years of age, was diagnosed with alanine aminotransferase increased, hepatitis b dna assay, lymphoma and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: neutropenia. BARACLUDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

BARACLUDE problem was reported by a Physician from JAPAN on June 26, 2007. Male patient, 49 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic function abnormal, white blood cell count decreased. BARACLUDE dosage: unknown. During the same period patient was treated with LASIX, ALDACTONE, LIVACT, NEO MINOPHAGEN C, FESIN, CISPLATIN. Patient recovered.

Physician from JAPAN reported BARACLUDE problem on July 02, 2007. Male patient, 49 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, white blood cell count decreased. BARACLUDE dosage: unknown. During the same period patient was treated with LASIX, ALDACTONE, LIVACT, NEO MINOPHAGEN C, FESIN, CISPLATIN. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from SINGAPORE on July 09, 2007. Male patient, 52 years of age, was treated with BARACLUDE. BARACLUDE dosage: unknown. Patient died on 06/04/2007.

Physician from JAPAN reported BARACLUDE problem on July 06, 2007. Male patient, 69 years of age, was diagnosed with hepatic cirrhosis and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, peritonitis bacterial. BARACLUDE dosage: unknown. During the same period patient was treated with URIEF. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Pharmacist from JAPAN on July 12, 2007. Male patient, 66 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: urinary retention. BARACLUDE dosage: unknown. During the same period patient was treated with FLOMOX, EMPYNASE, LOXONIN. Patient recovered.

Pharmacist from JAPAN reported BARACLUDE problem on July 17, 2007. Male patient, 65 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: dysuria, herpes zoster, urinary retention. BARACLUDE dosage: unknown. During the same period patient was treated with FLOMOX, EMPYNASE, LOXONIN. Patient was hospitalized and became disabled. Patient recovered.

BARACLUDE problem was reported by a Physician from GERMANY on July 16, 2007. Female patient, 63 years of age, weighting 132.3 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: lymphoma. BARACLUDE dosage: unknown. Patient recovered.

Physician from SWITZERLAND reported BARACLUDE problem on July 16, 2007. Female patient, 49 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: viral mutation identified. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from CHINA on July 23, 2007. Male patient, 32 years of age, weighting 138.9 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome. BARACLUDE dosage: unknown. During the same period patient was treated with ESSENTIALE, TIOPRONIN. Patient recovered.

Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on July 26, 2007. Male patient, 68 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. BARACLUDE dosage: unknown. Patient died on 04/17/2007.

BARACLUDE problem was reported by a Consumer or non-health professional from SINGAPORE on July 27, 2007. Female patient, 70 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatitis b. BARACLUDE dosage: unknown. Patient died.

Physician from GERMANY reported BARACLUDE problem on Aug 01, 2007. Male patient, 52 years of age, was diagnosed with hepatitis b, polyarthritis, reflux oesophagitis and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal hypomotility, pneumonia, sepsis, subileus, tracheobronchitis. BARACLUDE dosage: unknown. During the same period patient was treated with PREDNISONE, AZULFIDINE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

BARACLUDE problem was reported by a Pharmacist from GERMANY on Aug 06, 2007. Male patient, 35 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: epilepsy. BARACLUDE dosage: unknown. During the same period patient was treated with DOCITON, PHYTOMENADIONE. Patient recovered.

Health Professional from JAPAN reported BARACLUDE problem on Aug 10, 2007. Male patient, 58 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction. BARACLUDE dosage: unknown. Patient recovered.

BARACLUDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 20, 2007. Male patient, 60 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic failure. BARACLUDE dosage: unknown. During the same period patient was treated with LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported BARACLUDE problem on Aug 22, 2007. Male patient, 90 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant. BARACLUDE dosage: unknown. Patient was hospitalized. Patient recovered.

Showing 1-75 of 169 Next >

Ask Our Patient Community about BARACLUDE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase (prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirta